JP Morgan Chase’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $205 | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $25.5K | Buy |
|
|||||
|
2024
Q3 | $2.78K | Hold |
|
|||||
|
2024
Q2 | $1.15K | Sell |
|
|||||
|
2024
Q1 | $886K | Sell |
|
|||||
|
2023
Q4 | $746K | Sell |
|
|||||
|
2023
Q3 | $843K | Sell |
|
|||||
|
2023
Q2 | $1.93M | Sell |
|
|||||
|
2023
Q1 | $2.77M | Buy |
|
|||||
|
2022
Q4 | $4.91M | Buy |
|
|||||
|
2022
Q3 | $7.56M | Buy |
|
|||||
|
2022
Q2 | $6.25M | Buy |
|
|||||
|
2022
Q1 | $8.73M | Sell |
|
|||||
|
2021
Q4 | $11.9M | Sell |
|
|||||
|
2021
Q3 | $18.2M | Sell |
|
|||||
|
2021
Q2 | $39.2M | Buy |
|
|||||
|
2021
Q1 | $35.8M | Buy |
|
|||||
|
2020
Q4 | $27.8M | Buy |
|
|||||
|
2020
Q3 | $9.69M | Buy |
|
|||||
|
2020
Q2 | $6.92M | Buy |
|
|||||
|
2020
Q1 | $3.97M | Buy |
|
|||||
|
2019
Q4 | $2.52M | Buy |
|
|||||
|
2019
Q3 | $980K | Buy |
|
|||||
|
2019
Q2 | $1.05M | Buy |
|
|||||
|
2019
Q1 | $931K | Sell |
|
|||||
|
2018
Q4 | $1.19M | Sell |
|
|||||
|
2018
Q3 | $1.79M | Buy |
|
|||||
|
2018
Q2 | $1.39M | Sell |
|
|||||
|
2018
Q1 | $1.88M | Buy |
|
|||||
|
2017
Q4 | $344K | Buy |
|
|||||
|
2017
Q3 | $32K | Buy |
|
|||||
|
2017
Q2 | $18K | Sell |
|
|||||
|
2017
Q1 | $61K | Buy |
|
|||||
|
2016
Q4 | $4K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $4K | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|
|||||
|
2015
Q4 | $1K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.9M | Buy |
|
|||||
|
2014
Q4 | $1.66M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $435K | Sell |
|
|||||
|
2013
Q2 | $464K | Buy |
|